Table 3 Postoperative parameters of 559 advanced EOC patients having cytoreductive surgery. A total of 185, 194, and 180 patients were treated during the baseline, transition, and evaluation years, respectively. Numbers are shown either as absolute numbers with percentage unless otherwise indicated

Postoperative Admissions

< 0.0001

 Regular Ward Admission

170 (91.9%)

138 (71.1%)

124 (68.9%)

 Pre-planned HDU/ITU Admission

1 (0.5%)

19 (9.8%)

32 (17.8%)

 Planned HDU/ITU Admission

7 (3.8%)

33 (17.0%)

20 (11.1%)

 Unplanned HDU/ITU Admission

7 (3.8%)

4 (2.1%)

4 (2.2%)

Hospital Stay (days)

Mean ± SD

7.0 ± 2.6

8.3 ± 4.9

8.4 ± 4.9

0.0014

Chemotherapy Regimen^a

0.449

 No Adjuvant CT

18 (9.7%)

27 (13.9%)

21 (11.7%)

 Adjuvant CT

167 (90.3%)

167 (86.1%)

159 (88.3%)

Planned Adjuvant CT^b

0.811

 Started ≤ 6w after surgery

157 (94.0%)

154 (92.2%)

148 (93.1%)

 Started > 6w after surgery

10 (6.0%)

13 (7.8%)

11 (6.9%)

Peri-operative Morbidity

0.142

 Clavien-Dindo Grade 0–2

167 (90.3%)

180 (92.8%)

156 (86.7%)

 Clavien-Dindo Grade ≥ 3 A

18 (9.7%)

14 (7.2%)

24 (13.3%)

Postoperative Mortality

0.635

 Alive after 60-days

182 (98.4%)

193 (99.5%)

179 (99.4%)

 Death < 30-days

1 (0.5%)

0 (0.0%)

0 (0.0%)

 30-days ≤ Death < 60-days

2 (1.1%)

1 (0.5%)

1 (0.6%)